Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefeng Qiu

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Biomed Research International|September 10, 2015
Basic Fibroblast Growth Factor Ameliorates Endothelial Dysfunction in Radiation-Induced Bladder InjuryShiwei Zhang, Xuefeng Qiu, Yanting Zhang, et al.
Molecular Pharmaceutics|December 30, 2015
Photothermal Ablation of in Situ Renal Tumor by PEG-IR780-C13 Micelles and Near-Infrared IrradiationXuefeng Qiu, Linfeng Xu, Yanting Zhang, et al.
Toxicology and Applied Pharmacology|May 20, 2015
Roles of miRNAs in microcystin-LR-induced Sertoli cell toxicityYuan Zhou, Hui Wang, Cong Wang, et al.
Prostate Cancer and Prostatic Diseases|December 26, 2025
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 studyTangtao Gong, Shuo Liang, Zhigang Wu, et al.
Frontiers in Oncology|January 30, 2023
A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recoveryYuwen Wang, Shun Zhang, Haifeng Huang, et al.
BMC Urology|April 2, 2024
Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogramYongbing Cheng, Bo Fan, Yao Fu, et al.
World Journal of Urology|January 3, 2025
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trialXuyu Zhang, Feng Zhou, Tong Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2025
Pathological and radiological features of false-positive lesions on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysisRenjie Li, Yao Fu, Shan Peng, et al.
Scientific Reports|August 24, 2016
Scalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible HydrogelsQiang Li, Haishuang Lin, Ou Wang, et al.
Urologic Oncology|January 17, 2024
The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapyBinyu Wang, Yao Fu, Mengxia Chen, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Biomed Research International|September 10, 2015
Basic Fibroblast Growth Factor Ameliorates Endothelial Dysfunction in Radiation-Induced Bladder InjuryShiwei Zhang, Xuefeng Qiu, Yanting Zhang, et al.
Molecular Pharmaceutics|December 30, 2015
Photothermal Ablation of in Situ Renal Tumor by PEG-IR780-C13 Micelles and Near-Infrared IrradiationXuefeng Qiu, Linfeng Xu, Yanting Zhang, et al.
Toxicology and Applied Pharmacology|May 20, 2015
Roles of miRNAs in microcystin-LR-induced Sertoli cell toxicityYuan Zhou, Hui Wang, Cong Wang, et al.
Prostate Cancer and Prostatic Diseases|December 26, 2025
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 studyTangtao Gong, Shuo Liang, Zhigang Wu, et al.
Frontiers in Oncology|January 30, 2023
A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recoveryYuwen Wang, Shun Zhang, Haifeng Huang, et al.
BMC Urology|April 2, 2024
Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogramYongbing Cheng, Bo Fan, Yao Fu, et al.
World Journal of Urology|January 3, 2025
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trialXuyu Zhang, Feng Zhou, Tong Lu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2025
Pathological and radiological features of false-positive lesions on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysisRenjie Li, Yao Fu, Shan Peng, et al.
Scientific Reports|August 24, 2016
Scalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible HydrogelsQiang Li, Haishuang Lin, Ou Wang, et al.
Urologic Oncology|January 17, 2024
The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapyBinyu Wang, Yao Fu, Mengxia Chen, et al.
Pageof 14